Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 67, Issue 3, Pages (September 2017)

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Jordi Bruix, Maria Reig, Morris Sherman Gastroenterology

Volume 56, Issue 4, Pages (April 2012)

MELD: the holy grail of organ allocation?

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis Wichit Srikureja,

Volume 68, Issue 5, Pages (May 2018)

Jordi Bruix, Maria Reig, Morris Sherman Gastroenterology

Primary prevention of variceal haemorrhage: A pharmacological approach

Volume 61, Issue 6, Pages (December 2014)

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Non-invasive diagnosis of non-alcoholic fatty liver disease

Living donor liver transplantation: is the hype over?

Reply to: “DCD consensus and futility in liver transplantation”

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

The place of downstaging for hepatocellular carcinoma

Volume 58, Issue 3, Pages (March 2013)

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.

Mauro Bernardi, Stefano Gitto, Maurizio Biselli Journal of Hepatology

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable? Jian Wu, Wei Bai,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Liver cancer: Approaching a personalized care

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Volume 62, Issue 3, Pages (March 2015)

Management of cirrhosis due to chronic hepatitis C

Volume 57, Issue 4, Pages (October 2012)

Volume 66, Issue 2, Pages (February 2017)

Who should get a liver graft?

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Wolfgang Sieghart, Florian Hucke, Markus Peck-Radosavljevic

Eric S. Orman, Marwan Ghabril, Naga Chalasani

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Chetana Lim, Chady Salloum, Daniel Azoulay

Evolution of liver transplantation for hepatocellular carcinoma

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Volume 42, Issue 4, Pages (April 2005)

Liver Transplantation for Hepatocellular Carcinoma

New trials and results in systemic treatment of HCC

Liver transplantation in children

Volume 60, Issue 6, Pages (June 2014)

Pathogenesis of cholestatic hepatitis C

Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing Roongruedee Chaiteerakij,

Jordi Bruix, Maria Reig, Morris Sherman Gastroenterology

MELD: the holy grail of organ allocation?

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Reversion of disease manifestations after HCV eradication

Volume 60, Issue 6, Pages (June 2014)

Friedrich Foerster, Peter Robert Galle JHEP Reports

Presentation transcript:

Reply to: “Performance status in patients with HCC: New kid on the block” Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology Volume 67, Issue 6, Pages 1353-1355 (December 2017) DOI: 10.1016/j.jhep.2017.07.029 Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Staging and treatment according to the Barcelona Clinic Liver Cancer (BCLC) system. *Note that Child-Pugh classification is not sensitive enough to accurately identify those patients with advanced liver failure that would deserve liver transplant consideration. **Patients with end stage cirrhosis due to heavily impaired liver function (Child-Pugh C or earlier stages with predictors of poor prognosis, high MELD score) should be considered for liver transplantation. In these patients, HCC may become a contraindication if exceeding the enlistment criteria. Adapted from.4 Journal of Hepatology 2017 67, 1353-1355DOI: (10.1016/j.jhep.2017.07.029) Copyright © 2017 European Association for the Study of the Liver Terms and Conditions